Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
| Treament | Trials | |||||
|---|---|---|---|---|---|---|
| clinical deterioration | clinical improvement | deaths | viral clearance | |||
| CoronaVac (SinoVac) | 0 | - | - | - | - | |
| Covaxin, Bharat Biotech (BBV152) | 0 | - | - | - | - | |
| Shifa-Pharmed inactivated vaccine | 0 | - | - | - | - | |
| Sinopharm Beijing (BBIBP-CorV) | 0 | - | - | - | - | |
| Sinopharm Wuhan | 0 | - | - | - | - | |